![June Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
June Lee
Direktor/Vorstandsmitglied bei
ELEDON PHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2026
Profil
June Lee ist Mitglied des Vorstands von Eledon Pharmaceuticals, Inc. und Vorsitzende des Council of Korean Americans. In ihrer bisherigen Laufbahn war sie Chief Development Officer & Executive VP bei MyoKardia, Inc. und Medical Director bei Genentech, Inc. sowie Director-Translational Research & Catalyst Program an der University of California, San Francisco und Professorin an der California University of Science & Medicine. June Lee erhielt einen Bachelor-Abschluss von der Johns Hopkins University School of Medicine und einen Doktortitel von der UC Davis School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 28.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
ABIVAX SA -.--% | 28.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von June Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.12.2020 |
| TENAYA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.11.2021 |
| ABIVAX | Direktor/Vorstandsmitglied | 11.07.2023 |
| NKGEN BIOTECH KOREA CO., LTD. | Direktor/Vorstandsmitglied | 21.11.2025 |
Council of Korean Americans | Direktor/Vorstandsmitglied | - |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Direktor/Vorstandsmitglied | - |
University of California Drug Discovery Consortium | Vorsitzender | - |
Ehemalige bekannte Positionen von June Lee
| Unternehmen | Position | Ende |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 30.11.2024 |
| CINCOR PHARMA, INC. | Direktor/Vorstandsmitglied | 24.02.2023 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von June Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Council of Korean Americans | |
NKMAX Co., Ltd. (South korea)
 NKMAX Co., Ltd. (South korea) BiotechnologyHealth Technology Manufactures biological products | Health Technology |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
University of California Drug Discovery Consortium |
